Agilent Technologies Inc. Acquires Manufacturer Of Synthetic Nucleic Acids For Pharmaceutical And Biotech Industries

PALO ALTO, Calif.--(BUSINESS WIRE)--April 17, 2006--Agilent Technologies Inc. (NYSE:A - News) today announced that it has acquired privately held SynPro Corp., the owner of a contract manufacturing facility established to supply active pharmaceutical ingredients and provide related services. Financial details were not disclosed.
MORE ON THIS TOPIC